======= TJP2 =======
== Gene Information ==
* **Official Symbol**: TJP2
* **Official Name**: tight junction protein 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9414|9414]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UDY2|Q9UDY2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TJP2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TJP2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607709|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a zonula occluden that is a member of the membrane-associated guanylate kinase homolog family. The encoded protein functions as a component of the tight junction barrier in epithelial and endothelial cells and is necessary for proper assembly of tight junctions. Mutations in this gene have been identified in patients with hypercholanemia, and genomic duplication of a 270 kb region including this gene causes autosomal dominant deafness-51. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].
* **UniProt Summary**: N/A
|PDZ|
|SH3 2|
|Guanylate kin|
|guanylate kinase activity|
|GDP metabolic process|
|establishment of endothelial intestinal barrier|
|GMP metabolic process|
|hippo signaling|
|establishment of endothelial barrier|
|intestinal absorption|
|purine ribonucleoside monophosphate metabolic process|
|purine nucleoside monophosphate metabolic process|
|guanosine-containing compound metabolic process|
|endothelial cell development|
|ribonucleoside monophosphate metabolic process|
|purine ribonucleoside metabolic process|
|purine nucleoside diphosphate metabolic process|
|purine ribonucleoside diphosphate metabolic process|
|adherens junction|
|purine nucleoside metabolic process|
|ribonucleoside diphosphate metabolic process|
|nucleoside monophosphate metabolic process|
|digestive system process|
|ribonucleoside metabolic process|
|protein binding, bridging|
|regulation of membrane permeability|
|nucleoside diphosphate metabolic process|
|endothelial cell differentiation|
|endothelium development|
|nucleoside metabolic process|
|digestion|
|bicellular tight junction|
|glycosyl compound metabolic process|
|epithelial cell development|
|protein domain specific binding|
|cadherin binding|
|purine ribonucleotide metabolic process|
|ribonucleotide metabolic process|
|purine nucleotide metabolic process|
|ribose phosphate metabolic process|
|purine-containing compound metabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|nucleobase-containing small molecule metabolic process|
|cell junction|
|epithelial cell differentiation|
|organophosphate metabolic process|
|carbohydrate derivative metabolic process|
|epithelium development|
|cell development|
|intracellular signal transduction|
|small molecule metabolic process|
|tissue development|
|system process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|1.83|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 14592
* **Expression level (log2 read counts)**: 2.15
{{:chemogenomics:nalm6 dist.png?nolink |}}